Summary The chemical carcinogen 7,12-dimethylbenz (a) anthracene (DMBA) is a potent carcinogen which, when applied to the skin of BALB/c mice weekly for 7-8 weeks, causes the induction of macroscopically visible skin tumours. We report that DMBA also depletes Langerhans cells (LC) the chemical carcinogen 7,12-dimethylbenz (a) anthracene (DMBA) on LC numbers and morphology as assessed by adenosine triphosphatase (ATPase) staining during the induction and growth of DMBA-induced skin tumours. DMBA caused depletion of LC from skin surrounding the tumours, and the LC reappeared as the tumours ceased growing. The time scale of reappearance of LC suggests they were being repopulated from bone-marrow derived precursors.
Langerhans cells (LC) are the initial cells involved in a local immune response against antigens in the skin, where they function as antigen-presenting cells (Halliday & Muller, 1984) . They are bone marrow derived dendritic cells (Stingl et al., 1980) which bind antigen (Shelley & Juhlin, 1976) and transport it to the local lymph nodes (Silberberg-Sinakin et al., 1977) for presentation to T cells, resulting in a specific immune response against the antigen.
LC have been shown to be necessary for initiation of immune responses both in vivo and in vitro. In vivo studies of mouse skin depleted of LC by ultraviolet (UV) light irradiation have shown that LC are necessary for the induction of contact sensitivity (Toews et al., 1980) . In these experiments skin depleted of LC by UV-light could not support initiation of contact sensitivity, although contact sensitivity could be initiated via untreated skin. Thus local depletion of LC abolished the potential for an immune response against antigens in that locality, while a normal immune response could be initiated against antigens in other sites. In vitro studies using monocyte-depleted lymphocytes cultured with epidermal LC and antigen have formally proven that LC are able to present antigen to lymphocytes, initiating a specific immune response (Stingl et al., 1978; Braathen & Thorsby, 1983 
Materials and methods
Carcinogen treatment of mice Male BALB/c mice were obtained from Walter and Eliza Hall Institute, Melbourne; from 8-9 weeks of age they were treated with 7,12-dimethylbenz (a) anthracene (DMBA, Sigma, USA, Lot 24F-0052) as described by Muller & Flannery (1973) . The dorsal trunk skin of the mice was shaved with electric clippers and painted with 1% DMBA dissolved in equal volumes of lanoline (Sigma, USA) and liquid paraffin (Supply and Tender, Hobart); control mice received solvent alone.
To determine the early effects of DMBA on LC before tumours became apparent, groups of 4 mice were treated with DMBA. The first application of DMBA was designated as being on day 0, with weekly applications for up to 4 weeks; mice being killed 3 or 7 days following the last treatment. To determine the LC density in DMBA-treated skin during growth of DMBA-induced tumours, the DMBA was applied weekly for [7] [8] (PBS/Mg 5), and the stratum corneum and dermal layers were gently removed from the epidermis using fine forceps and a dissecting microscope.
A TPase staining of LC Epidermal sheets were stained for the enzyme adenosine triphosphatase (ATPase) by a method adapted from those of Baker & Habowsky (1983) and Daniels (1984) . Epidermal sheets were washed in PBS/Mg+ +; fixed in cacodylate-buffered 2% formaldehyde (pH 7.3) for 20min at 4°C; washed with 3 changes of saline over Omin; stained for 1 h at 37°C with 21 mM trizma-maleate buffer (pH 7.3, Sigma, USA, Lot 61C-5130) containing 0.36mM disodium adenosine triphosphate (ATP, vanadium free, Sigma, USA, Lot 91F-7165), 10.37mM MgSO4, 2.2 mM Pb(NO03)2, and 0.25 M sucrose; washed with 2 changes of saline over 5 min; developed with 2 drops of 20% ammonium sulfide in 50 ml distilled water for 5 min at room temperature; and washed with 2 changes of saline over 5 min. The sheets were then counterstained with 2% methyl green (Schmid and Co., W.
Germany, Lot 11105) in distilled water for 5min, washed with 3 changes of saline over Omin, and mounted on glass slides, with the dermal surface down, in glycerin: PBS (9:1, v:v).
Enumeration of LC in epidermal sheets
For each mouse the number of LC in the dorsal trunk skin were enumerated microscopically in 4 replicate epidermal sheets, the total area being 2.5 mm2. To correct for stretching during preparation the area of each sheet was measured using a Bioquant II basic measuring program Figure 2 , the means for 10 day periods are shown in Table I . Tumours were becoming visible macroscopically during this time period (Table I ). All cutaneous lesions had appeared by day 24, with an average of 3 per mouse and a range of 1 to 8. The tumours showed a spectrum of disordered cell growth ranging from squamous papillomas and keratoacanthomas to a few squamous cell carcinomas. The remainder of the lesions were identified as squamous keratoses. The tumours commenced to reduce in size by day 25, with 48% regressing by days 55-64 (Table I) (Rowden, 1981) . Epidermal sheets were prepared by modification of a procedure which used incubation in EDTA at 37°C for 2.5 h to enable separation of dermis from epidermis (Baker & Habowsky, 1983) . We found that inclusion of . nL low concentration trypsin (0.001%), and incubation at room temperature overnight improved the LC morphology and ATPase staining, producing epidermal sheets in which the LC were observed to link with each other via their dendrites, allowing them to be more accurately quantitated. Using this procedure control BALB/c mice were found to have LC densities ranging from 340 to 690mm 2. Although other mouse strains have been reported with higher dorsal trunk epidermal LC densities e.g. 760 mm 2 for C57BL mice and 880 mm-2 for A/Jax mice , reported mean LC densities in normal epidermis vary considerably; in the case of human anterior forearm skin from 458mm 2 (Berman et al., 1983) to 720mm-2 (Friedmann, 1981) .
It is possible that identification of LC by the surface membrane component ATPase may detect modulation of the enzyme rather than disappearance of the cell, however it is not practical to count LC densities by electron microscopy, and any disruption of the plasma membrane which results in loss of ATPase should render the cells non-functional and alter their antigen trapping and presentation capabilities. Following exposure of mouse skin to UV-light, Aberer et al. (1981) found LC to be present by electron microscopy, although they were damaged and lacking in ATPase. In contrast Noonan et al. (1984) reported UV-light to deplete LC on both electron microscopy and ATPase staining criteria.
Glucocorticoid-mediated loss of ATPase from the LC membrane has been observed to require 7 days for the ATPase to be re-expressed on the LC membrane (Belsito et al., 1984) . In our experiments, the DMBA-treated LC-ATPase did not return to control values until 55-64 days following cessation of DMBA treatment. Considering this long recovery time, it is likely that DMBA depletes LC from the epidermis, and that the ATPase-positive cells which reappear in the epidermis following treatment are LC repopulating the epidermis rather than the original population re-expressing lost surface membrane ATPase. LC may repopulate the epidermis either from bone marrow precursors or from mitosis of residual LC. The time period required for the ATPase-positive cells to repopulate the epidermis is similar to the time required for donor bone marrow precursors to replace epidermal LC in chimeric mice . Repeated stripping of skin with adhesive tape, and dinitrochlorobenzene, both increase tritiated thymidine uptake in guinea pig LC, and although this may be due to proliferation of LC, it could also be due to increased DNA turnover during recovery of damaged LC (Gschnait & Brenner, 1979) , particularly as mitosis of LC has only been observed on a few occasions (Rowden, 1981) . Thus we concluded that the majority of the repopulated LC probably arose from bone-marrow precursors rather than from mitosis of residual LC. These experiments do not determine whether DMBA destroys the LC or causes it to leave the epidermis.
DMBA is known to depress natural killer cell activity (Kalland & Forsberg, 1983) , thus inhibiting an immune effector mechanism against the tumour. DMBA has also been shown to react with deoxyadenosine in the DNA of mouse skin, indicating that its tumour inducing activity may be caused by a direct effect on DNA (Bigger et al., 1983; Dipple et al., 1983) . However, our results suggest that as well as acting as a tumour inducer, DMBA also impairs immune surveillance by depleting epidermal antigen-presenting cells. This carcinogen-induced loss of LC may thus eliminate the potential for an immune response to develop against the transformed squamous cells, allowing these cells to proliferate.
It is also possible that the depletion of LC could result in the development of tumour-specific immunosuppression. Ptak et al. (1980) found that antigen coupled to epidermal cells induced immunity when injected intravenously, whereas antigen coupled to peritoneal exudate cells induced specific immunological unresponsiveness. It is possible that in the absence of LC, tumour antigens may filter through the skin and be presented to lymphocytes by monocytes, resulting in unresponsiveness. Further support for this comes from experiments by Toews et al. (1980) , who reported that antigen applied to skin depleted of LC by UV-light resulted in specific unresponsiveness. However, Noonan et al. (1984) , by using different wavelengths of UV-light claim that the UV-induced loss of LC is not responsible for the UV-induced systemic suppression; this requires further investigation.
The reduction in tumour size observed as the LC migrated back into the epidermis also suggests that the LC may be involved in an immune response against the tumours. However the mechanism of tumour regression has not been investigated, and its relationship with LC repopulation may be coincidental.
Finally, whether this DMBA-induced depletion of antigen-presenting cells is a general phenomenon associated with the induction of all tumours will only be apparent when the effects of other carcinogens are examined on other antigenpresenting cells in different regions of the body.
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